Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryota Hashimoto

Showing results (401-410 of 467) with videos related to

Pageof 47
Sort By:
Psychiatry and Clinical Neurosciences|March 11, 2026
Psychometrics of BE-PSD-V2.0 and its correspondence with PANSS and CGI-SHiroyoshi Takeuchi, Naoki Hashimoto, Yoshiteru Takekita, et al.
Schizophrenia (Heidelberg, Germany)|March 6, 2026
An ENIGMA Consortium study of the relationship between white matter microstructure and positive and negative symptom severity in patients with schizophreniaAoife Warren, Laurena Holleran, Ingrid Agartz, et al.
Neuropsychopharmacology Reports|October 18, 2022
Development of individual fitness score for conformity of prescriptions to the "Guidelines For Pharmacological Therapy of Schizophrenia"Ken Inada, Kentaro Fukumoto, Naomi Hasegawa, et al.
Journal of Clinical Psychopharmacology|October 4, 2022
Second-Generation Antipsychotic Monotherapy Contributes to the Discontinuation of Anticholinergic Drugs in Hospitalized Patients With SchizophreniaTsuyoshi Okada, Hikaru Hori, Naomi Hasegawa, et al.
Psychiatry and Clinical Neurosciences|September 9, 2023
Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter studyNaomi Hasegawa, Yuka Yasuda, Norio Yasui-Furukori, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 12, 2026
Empirical validation of race-neutral normative brain morphometry models across ethnoracially diverse populationsRuiyang Ge, Yuetong Yu, Faye New, et al.
Molecular Brain|August 21, 2015
Associations between the orexin (hypocretin) receptor 2 gene polymorphism Val308Ile and nicotine dependence in genome-wide and subsequent association studiesDaisuke Nishizawa, Shinya Kasai, Junko Hasegawa, et al.
Neuropsychopharmacology Reports|February 26, 2025
Proposal for a Novel Classification of Patients With Enlarged Ventricles and Cognitive Impairment Based on Data-Driven Analysis of Neuroimaging Results in Patients With Psychiatric DisordersYuka Yasuda, Satsuki Ito, Junya Matsumoto, et al.
Neuropsychopharmacology Reports|March 10, 2022
Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatryKazuyoshi Ogasawara, Shusuke Numata, Naomi Hasegawa, et al.
Bjpsych Open|April 21, 2022
A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) projectHisashi Yamada, Mikuni Motoyama, Naomi Hasegawa, et al.
Pageof 47

Showing results (401-410 of 467) with videos related to

Sort By:
Pageof 47
Psychiatry and Clinical Neurosciences|March 11, 2026
Psychometrics of BE-PSD-V2.0 and its correspondence with PANSS and CGI-SHiroyoshi Takeuchi, Naoki Hashimoto, Yoshiteru Takekita, et al.
Schizophrenia (Heidelberg, Germany)|March 6, 2026
An ENIGMA Consortium study of the relationship between white matter microstructure and positive and negative symptom severity in patients with schizophreniaAoife Warren, Laurena Holleran, Ingrid Agartz, et al.
Neuropsychopharmacology Reports|October 18, 2022
Development of individual fitness score for conformity of prescriptions to the "Guidelines For Pharmacological Therapy of Schizophrenia"Ken Inada, Kentaro Fukumoto, Naomi Hasegawa, et al.
Journal of Clinical Psychopharmacology|October 4, 2022
Second-Generation Antipsychotic Monotherapy Contributes to the Discontinuation of Anticholinergic Drugs in Hospitalized Patients With SchizophreniaTsuyoshi Okada, Hikaru Hori, Naomi Hasegawa, et al.
Psychiatry and Clinical Neurosciences|September 9, 2023
Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter studyNaomi Hasegawa, Yuka Yasuda, Norio Yasui-Furukori, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 12, 2026
Empirical validation of race-neutral normative brain morphometry models across ethnoracially diverse populationsRuiyang Ge, Yuetong Yu, Faye New, et al.
Molecular Brain|August 21, 2015
Associations between the orexin (hypocretin) receptor 2 gene polymorphism Val308Ile and nicotine dependence in genome-wide and subsequent association studiesDaisuke Nishizawa, Shinya Kasai, Junko Hasegawa, et al.
Neuropsychopharmacology Reports|February 26, 2025
Proposal for a Novel Classification of Patients With Enlarged Ventricles and Cognitive Impairment Based on Data-Driven Analysis of Neuroimaging Results in Patients With Psychiatric DisordersYuka Yasuda, Satsuki Ito, Junya Matsumoto, et al.
Neuropsychopharmacology Reports|March 10, 2022
Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatryKazuyoshi Ogasawara, Shusuke Numata, Naomi Hasegawa, et al.
Bjpsych Open|April 21, 2022
A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) projectHisashi Yamada, Mikuni Motoyama, Naomi Hasegawa, et al.
Pageof 47